Regulated Induced Proximity Targeting Chimeras
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
33
NCT06800313
A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Phase: Phase 1/2
Role: Lead Sponsor
Start: Feb 24, 2025
Completion: Mar 31, 2027
Loading map...